1[1]Mohamed A K, Bierhaus A, Schiekofer S, et al. The role of oxidative stress and NF-kappa B activation in late diabetic com plication. Biofactor, 1999,10: 157～ 167.
2[2]Morigi M, Anglolettl S, Imbertti B, et al. Leukocyte endothe lial interaction is augmented by high glucose concentration andhyperglycemia in a NF-kB dependent fashion. J Clin Invest, 1998, 10:1905～1915.
3[3]Nawroth P P, Biehaus A, Vogel G E, et al. Non-enzymatic glycation and oxidative stress in chronic illness and diabetes mellitus. Med Clin, 1999,94: 29 ～38.
4[4]Hofmann M A, Schiekofer S, Isermann B, et al. Peripheralblood mononuclear cells isolated from patients with increased activation of the transcription factor NF kappa B. Diabetologia, 1999,42: 222～232.
5[5]Marion A, Hofmann M D, Stephan D M, ct al. Insufficient glycemic control increases nuclear factor kappa B binding activi ty in peripheral blood mononuclear cells isolated from patients with typel diabetes. Diabetes Care, 1998,21:1310～1316.
6[6]Pieper G M, Riaz 1 H. Activation of nuclear factor-kappa B in cultured endothelial cells by increased glucose concentration: prevention by calphostin C. J Cardiovasc Pharmacol, 1997, 30:528～532.
7[7]Bierhaus A, Chevion S, Chevion M, et al. Advanced glycation end production induced activation of NE-kappa B is suppressed by alpha-lipoie acid in cultured endothelial cells. Diabetes, 1997, 46: 1481 ～ 1490.
8[8]Kawamura T, Umemura T, Kanai A, et al. The incidence and characteristics of silent cerebral infarction in elderly diabetic pa tients: association with serum soluble adhesion molecules. Dia betologia, 1998, 41:911～917.
9[9]Otsuki M, Hashimoto K, Morimoto Y, et al. Circulating vas cular cell adhesion molecule-1 (VCAM-1) in atheroscleroticNIDDM patients. Diabetes, 1997,46 : 2096～ 2101.
10[10]Matsumoto K, Sera Y, Nakamura H. Serum concentrations of soluble adhesion molecules are related to degree of hyperglyce mia and insulin resistance in patients with type 2 diabetes melli tus. Diabetes Res Clin Pract, 2002,55 : 131～ 138.
